Ajanta Pharma Ltd. Stock Soars 5.41%, Outperforms Sector and Sensex, Receives 'Buy' Call from MarketsMOJO
Ajanta Pharma Ltd., a leading pharmaceutical company in the largecap industry, has shown a 5.41% increase in its stock price on September 27, 2024, outperforming the sector by 0.64%. With a 'Buy' call from MarketsMojo, the company's consistent growth and positive performance make it a promising investment option for investors.
Ajanta Pharma Ltd., a leading pharmaceutical company in the largecap industry, has seen a positive growth in its stock price on September 27, 2024. The company's stock has gained 5.41%, outperforming the sector by 0.64%. This has led to a 'Buy' call by MarketsMOJO, a trusted source for stock analysis and recommendations.
The stock's performance today has been impressive, with Ajanta Pharma Ltd. surpassing the Sensex performance by 5.66%. The company's moving averages are also showing a positive trend, with all of them higher than the 5-day, 50-day, 100-day, and 200-day moving averages. However, the stock is currently lower than the 20-day moving average.
In comparison to the Sensex, Ajanta Pharma Ltd.'s 1-day performance has been significantly better, with a 5.41% increase compared to the Sensex's -0.25%. The company has also outperformed the Sensex in the past month, with a 12.62% growth compared to the Sensex's 4.78%.
Ajanta Pharma Ltd. has established itself as a major player in the pharmaceutical industry, with a strong presence in the largecap market. The company's consistent growth and positive performance make it a promising investment option for investors. With a 'Buy' call from MarketsMOJO, it is clear that Ajanta Pharma Ltd. is on the right track towards success.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
